Authorities in Thailand have intensified efforts to seize assets linked to Thapanan, a notorious narcotics trafficker apprehended in Seoul. Thapanan was arrested on April 6 following a collaborative investigation involving Thailand, Laos, South Korea, and Japan, ending a 14-year evasion amidst over 60 warrants for his arrest. Known for his resemblance to the infamous Khun Sa in terms of operational scale, he had altered his appearance through cosmetic surgery in South Korea to avoid detection.
Get today's headlines by email ![]()
Thapanan's criminal journey began in the early 2000s as a small-time dealer in Bangkok and evolved into a major supplier with international connections in Myanmar. A long-term target on the Narcotics Suppression Bureau's "Most Wanted" list, Thapanan leveraged prison ties to build a drug production network in Kokang, becoming a significant figure in the narcotics flow into Thailand. Authorities estimate his network may have handled up to 30% of narcotics entering the country, with capabilities to produce over 100 million meth pills annually.
The arrest culminated after a detailed investigation involving digital surveillance and international cooperation. Investigators tracked Thapanan’s movements through key associates, leading to his location in South Korea. Coordination with global agencies and a forensic fingerprint analysis confirmed his identity, resulting in an Interpol Red Notice and subsequent arrest by South Korean police.
Immediate plans involve the Office of the Narcotics Control Board and Anti-Money Laundering Office's efforts to confiscate assets linked to Thapanan, valued in the tens of millions of baht. The sprawling network spread across Thailand and Laos also suggests significant foreign assets, which authorities are aiming to track.
Looking Ahead, officials anticipate a complex process in seizing Thapanan's international assets, with further investigations underway to dismantle his operations comprehensively.
Adapted by ASEAN Now · Bangkok Post · 11 May 2026
Recommended Comments
Create an account or sign in to comment